Copyright Reports & Markets. All rights reserved.

Global Children Respiratory Syncytial Virus (RSV) Testing Market Insights, Forecast to 2028

Request for Sample of this report
Buy now

Table of Contents

    1 Report Business Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Testing Services
      • 1.2.3 Testing Kits
      • 1.2.4 Others
    • 1.3 Market by Application
      • 1.3.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Hospitals
      • 1.3.3 POCT
      • 1.3.4 Others
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Global Growth Trends

    • 2.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Perspective (2017-2028)
    • 2.2 Children Respiratory Syncytial Virus (RSV) Testing Growth Trends by Region
      • 2.2.1 Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region: 2017 VS 2021 VS 2028
      • 2.2.2 Children Respiratory Syncytial Virus (RSV) Testing Historic Market Size by Region (2017-2022)
      • 2.2.3 Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Region (2023-2028)
    • 2.3 Children Respiratory Syncytial Virus (RSV) Testing Market Dynamics
      • 2.3.1 Children Respiratory Syncytial Virus (RSV) Testing Industry Trends
      • 2.3.2 Children Respiratory Syncytial Virus (RSV) Testing Market Drivers
      • 2.3.3 Children Respiratory Syncytial Virus (RSV) Testing Market Challenges
      • 2.3.4 Children Respiratory Syncytial Virus (RSV) Testing Market Restraints

    3 Competition Landscape by Key Players

    • 3.1 Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Revenue
      • 3.1.1 Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Revenue (2017-2022)
      • 3.1.2 Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Players (2017-2022)
    • 3.2 Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Players Covered: Ranking by Children Respiratory Syncytial Virus (RSV) Testing Revenue
    • 3.4 Global Children Respiratory Syncytial Virus (RSV) Testing Market Concentration Ratio
      • 3.4.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Children Respiratory Syncytial Virus (RSV) Testing Revenue in 2021
    • 3.5 Children Respiratory Syncytial Virus (RSV) Testing Key Players Head office and Area Served
    • 3.6 Key Players Children Respiratory Syncytial Virus (RSV) Testing Product Solution and Service
    • 3.7 Date of Enter into Children Respiratory Syncytial Virus (RSV) Testing Market
    • 3.8 Mergers & Acquisitions, Expansion Plans

    4 Children Respiratory Syncytial Virus (RSV) Testing Breakdown Data by Type

    • 4.1 Global Children Respiratory Syncytial Virus (RSV) Testing Historic Market Size by Type (2017-2022)
    • 4.2 Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Type (2023-2028)

    5 Children Respiratory Syncytial Virus (RSV) Testing Breakdown Data by Application

    • 5.1 Global Children Respiratory Syncytial Virus (RSV) Testing Historic Market Size by Application (2017-2022)
    • 5.2 Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size (2017-2028)
    • 6.2 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type
      • 6.2.1 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2017-2022)
      • 6.2.2 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2023-2028)
      • 6.2.3 North America Children Respiratory Syncytial Virus (RSV) Testing Market Share by Type (2017-2028)
    • 6.3 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application
      • 6.3.1 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2017-2022)
      • 6.3.2 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2023-2028)
      • 6.3.3 North America Children Respiratory Syncytial Virus (RSV) Testing Market Share by Application (2017-2028)
    • 6.4 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country
      • 6.4.1 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2017-2022)
      • 6.4.2 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2023-2028)
      • 6.4.3 United States
      • 6.4.4 Canada

    7 Europe

    • 7.1 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size (2017-2028)
    • 7.2 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type
      • 7.2.1 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2017-2022)
      • 7.2.2 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2023-2028)
      • 7.2.3 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Share by Type (2017-2028)
    • 7.3 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application
      • 7.3.1 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2017-2022)
      • 7.3.2 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2023-2028)
      • 7.3.3 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Share by Application (2017-2028)
    • 7.4 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country
      • 7.4.1 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2017-2022)
      • 7.4.2 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2023-2028)
      • 7.4.3 Germany
      • 7.4.4 France
      • 7.4.5 U.K.
      • 7.4.6 Italy
      • 7.4.7 Russia
      • 7.4.8 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size (2017-2028)
    • 8.2 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type
      • 8.2.1 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2017-2022)
      • 8.2.2 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2023-2028)
      • 8.2.3 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Share by Type (2017-2028)
    • 8.3 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application
      • 8.3.1 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2017-2022)
      • 8.3.2 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2023-2028)
      • 8.3.3 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Share by Application (2017-2028)
    • 8.4 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region
      • 8.4.1 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2017-2022)
      • 8.4.2 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2023-2028)
      • 8.4.3 China
      • 8.4.4 Japan
      • 8.4.5 South Korea
      • 8.4.6 Southeast Asia
      • 8.4.7 India
      • 8.4.8 Australia

    9 Latin America

    • 9.1 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size (2017-2028)
    • 9.2 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type
      • 9.2.1 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2017-2022)
      • 9.2.2 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2023-2028)
      • 9.2.3 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Share by Type (2017-2028)
    • 9.3 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application
      • 9.3.1 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2017-2022)
      • 9.3.2 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2023-2028)
      • 9.3.3 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Share by Application (2017-2028)
    • 9.4 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country
      • 9.4.1 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2017-2022)
      • 9.4.2 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2023-2028)
      • 9.4.3 Mexico
      • 9.4.4 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size (2017-2028)
    • 10.2 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type
      • 10.2.1 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2017-2022)
      • 10.2.2 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2023-2028)
      • 10.2.3 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Share by Type (2017-2028)
    • 10.3 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application
      • 10.3.1 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2017-2022)
      • 10.3.2 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2023-2028)
      • 10.3.3 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Share by Application (2017-2028)
    • 10.4 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country
      • 10.4.1 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2017-2022)
      • 10.4.2 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2023-2028)
      • 10.4.3 Turkey
      • 10.4.4 Saudi Arabia
      • 10.4.5 UAE

    11 Key Players Profiles

    • 11.1 BD
      • 11.1.1 BD Company Details
      • 11.1.2 BD Business Overview
      • 11.1.3 BD Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.1.4 BD Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.1.5 BD Recent Developments
    • 11.2 Abbot (Alere)
      • 11.2.1 Abbot (Alere) Company Details
      • 11.2.2 Abbot (Alere) Business Overview
      • 11.2.3 Abbot (Alere) Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.2.4 Abbot (Alere) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.2.5 Abbot (Alere) Recent Developments
    • 11.3 Quidel
      • 11.3.1 Quidel Company Details
      • 11.3.2 Quidel Business Overview
      • 11.3.3 Quidel Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.3.4 Quidel Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.3.5 Quidel Recent Developments
    • 11.4 Roche
      • 11.4.1 Roche Company Details
      • 11.4.2 Roche Business Overview
      • 11.4.3 Roche Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.4.4 Roche Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.4.5 Roche Recent Developments
    • 11.5 Thermo Fisher Scientific
      • 11.5.1 Thermo Fisher Scientific Company Details
      • 11.5.2 Thermo Fisher Scientific Business Overview
      • 11.5.3 Thermo Fisher Scientific Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.5.4 Thermo Fisher Scientific Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.5.5 Thermo Fisher Scientific Recent Developments
    • 11.6 Meridian Bioscience
      • 11.6.1 Meridian Bioscience Company Details
      • 11.6.2 Meridian Bioscience Business Overview
      • 11.6.3 Meridian Bioscience Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.6.4 Meridian Bioscience Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.6.5 Meridian Bioscience Recent Developments
    • 11.7 OPERON
      • 11.7.1 OPERON Company Details
      • 11.7.2 OPERON Business Overview
      • 11.7.3 OPERON Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.7.4 OPERON Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.7.5 OPERON Recent Developments
    • 11.8 Laboratory Corporation of America
      • 11.8.1 Laboratory Corporation of America Company Details
      • 11.8.2 Laboratory Corporation of America Business Overview
      • 11.8.3 Laboratory Corporation of America Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.8.4 Laboratory Corporation of America Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.8.5 Laboratory Corporation of America Recent Developments
    • 11.9 BioMerieux
      • 11.9.1 BioMerieux Company Details
      • 11.9.2 BioMerieux Business Overview
      • 11.9.3 BioMerieux Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.9.4 BioMerieux Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.9.5 BioMerieux Recent Developments
    • 11.10 Sekisui Diagnostics
      • 11.10.1 Sekisui Diagnostics Company Details
      • 11.10.2 Sekisui Diagnostics Business Overview
      • 11.10.3 Sekisui Diagnostics Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.10.4 Sekisui Diagnostics Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.10.5 Sekisui Diagnostics Recent Developments
    • 11.11 Response Biomedical
      • 11.11.1 Response Biomedical Company Details
      • 11.11.2 Response Biomedical Business Overview
      • 11.11.3 Response Biomedical Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.11.4 Response Biomedical Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.11.5 Response Biomedical Recent Developments
    • 11.12 ARUP Laboratories
      • 11.12.1 ARUP Laboratories Company Details
      • 11.12.2 ARUP Laboratories Business Overview
      • 11.12.3 ARUP Laboratories Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.12.4 ARUP Laboratories Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.12.5 ARUP Laboratories Recent Developments
    • 11.13 DiaSorin (Focus Diagnostics)
      • 11.13.1 DiaSorin (Focus Diagnostics) Company Details
      • 11.13.2 DiaSorin (Focus Diagnostics) Business Overview
      • 11.13.3 DiaSorin (Focus Diagnostics) Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.13.4 DiaSorin (Focus Diagnostics) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.13.5 DiaSorin (Focus Diagnostics) Recent Developments
    • 11.14 Avellino
      • 11.14.1 Avellino Company Details
      • 11.14.2 Avellino Business Overview
      • 11.14.3 Avellino Children Respiratory Syncytial Virus (RSV) Testing Introduction
      • 11.14.4 Avellino Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2017-2022)
      • 11.14.5 Avellino Recent Developments

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Author Details

      Summary:

      Market Analysis and Insights: Global Children Respiratory Syncytial Virus (RSV) Testing Market
      The global Children Respiratory Syncytial Virus (RSV) Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
      Fully considering the economic change by this health crisis, Testing Services accounting for % of the Children Respiratory Syncytial Virus (RSV) Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
      China Children Respiratory Syncytial Virus (RSV) Testing market size is valued at US$ million in 2021, while the North America and Europe Children Respiratory Syncytial Virus (RSV) Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Children Respiratory Syncytial Virus (RSV) Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
      With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Children Respiratory Syncytial Virus (RSV) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Children Respiratory Syncytial Virus (RSV) Testing market in terms of revenue.
      Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Children Respiratory Syncytial Virus (RSV) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Children Respiratory Syncytial Virus (RSV) Testing market.
      Impact of Covid-19 Outbreak
      This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
      Segmental Analysis
      The report has been segmented into product and application segments. The researchers have documented all the products present today in the Children Respiratory Syncytial Virus (RSV) Testing market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
      Children Respiratory Syncytial Virus (RSV) Testing Breakdown Data by Type
      Testing Services
      Testing Kits
      Others
      Children Respiratory Syncytial Virus (RSV) Testing Breakdown Data by Application
      Hospitals
      POCT
      Others
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Nordic Countries
      Rest of Europe
      Asia-Pacific
      China
      Japan
      South Korea
      Southeast Asia
      India
      Australia
      Rest of Asia
      Latin America
      Mexico
      Brazil
      Rest of Latin America
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Rest of MEA
      Competitive Landscape
      This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
      BD
      Abbot (Alere)
      Quidel
      Roche
      Thermo Fisher Scientific
      Meridian Bioscience
      OPERON
      Laboratory Corporation of America
      BioMerieux
      Sekisui Diagnostics
      Response Biomedical
      ARUP Laboratories
      DiaSorin (Focus Diagnostics)
      Avellino
      Frequently Asked Questions
      What factors will challenge the Children Respiratory Syncytial Virus (RSV) Testing market growth?
      Which end-use segment will expand at the fastest CAGR in the Children Respiratory Syncytial Virus (RSV) Testing market?
      Which are the emerging players in the Children Respiratory Syncytial Virus (RSV) Testing market?
      How concentrated is the Children Respiratory Syncytial Virus (RSV) Testing market?
      Which factors are positively contributing to the Children Respiratory Syncytial Virus (RSV) Testing market growth?
      Which are the novel product innovations in the Children Respiratory Syncytial Virus (RSV) Testing market?
      Which product segment will emerge as the most lucrative in the Children Respiratory Syncytial Virus (RSV) Testing market?
      Which factors are increasing the competition in the Children Respiratory Syncytial Virus (RSV) Testing market?
      Which are the strategic measures taken by the Children Respiratory Syncytial Virus (RSV) Testing industry players?
      Which region will witness inactive growth during the forecast period?
      What key trends are likely to emerge in the Children Respiratory Syncytial Virus (RSV) Testing market in the coming years?
      Buy now